MarketsStocksJENBURPH
JE

Jenburkt Pharmaceuticals Ltd.

NSE: JENBURPHBSE: 524731Healthcare
Download Research Report7-page PDF
1,160.00
+1.96%
NSE · auto-updates while market open
Mkt Cap
₹526 Cr
P / E
15.1
P / B
2.7
ROE
18.8%
52W High
₹1,410.00
52W Low
₹944.00
Key Metrics
Market Cap
₹526 Cr
P / E
15.14
P / B
2.67
EV / EBITDA
11.35
ROCE
25.3%
ROE
18.8%
Debt / Equity
0.00
Book Value
₹446.47
EPS
₹78.71
Div Yield
0.0%
Face Value
-
Promoter Holding
46.6%
Revenue · ₹ Cr
124
FY22
137
FY23
142
FY24
152
FY25
169
FY26
Net Profit · ₹ Cr
22
FY22
25
FY23
26
FY24
32
FY25
35
FY26
EPS · ₹ per share
₹48.6
FY22
₹53.9
FY23
₹58.9
FY24
₹72.7
FY25
₹78.7
FY26
Q1 2026 snapshot
Sales
₹49 Cr
Operating profit
-
OPM
-
Net profit
₹11 Cr
EPS
₹24.58
Scorecard · 7 axes
Quality
Strong
84/100
Valuation
Good
15.1×
Growth
Avg
+9.9%
Profitability
Strong
22.1%
Performance
Bad
-14.1%
Entry Point
Avg
82%
Red Flags
Strong
0 flags
Shareholding Pattern
46.6%Promoter
Promoter46.6%
DII0.1%
Public53.2%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue38.4742.9337.5847.6444.8448.98
Net Profit6.5088.5377.79210.1635.93110.85
NPM %16.9%19.9%20.7%21.3%13.2%22.2%
AlertPre-trade